
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Guduchi (Tinospora cordifolia) is an Ayurvedic herb that enhances immune function through its primary alkaloid berberine and immunomodulatory compounds called tinosporides. It works by activating macrophages and stimulating T-lymphocyte proliferation while supporting liver detoxification through hepatoprotective mechanisms.

Reported Benefits (Provisional)
Origin & History

Guduchi, also known as Tinospora Cordifolia, is a climbing shrub native to India. It is harvested for its stems and roots, which are traditionally dried and powdered for medicinal use.
Research Narrative (Provisional)
Several human trials indicate guduchi's potential in boosting immunity and reducing inflammation. Animal studies further support its hepatoprotective effects.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains alkaloids, glycosides, and steroids. - Rich in antioxidants such as flavonoids. - Provides essential minerals like zinc and manganese.
Reported Mechanism (Provisional)
Guduchi's immunomodulatory effects are mediated by tinosporides and berberine, which activate the complement system and enhance phagocytic activity of macrophages. The herb stimulates cytokine production including interleukin-1β and tumor necrosis factor-α, while its hepatoprotective action occurs through antioxidant pathways involving glutathione peroxidase and catalase enzymes. Berberine also modulates NF-κB signaling pathways to reduce inflammatory responses.
Clinical Narrative (Provisional)
Human studies on guduchi show promising but limited evidence for immune enhancement. A randomized controlled trial with 60 participants found 300mg daily increased white blood cell count by 18% after 8 weeks. Small studies (20-40 subjects) suggest liver enzyme improvements in hepatitis patients, with ALT and AST reductions of 15-25%. However, most research consists of animal studies and preliminary human trials, requiring larger, longer-term clinical investigations to confirm therapeutic efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







